Clinical trial
High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Randomized Controlled Trial Comparing MitraClip® to Surgical Therapy
NCT02534155 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Randomized Controlled Trial Comparing MitraClip® to Surgical Therapy
- Lead sponsor
- University of Zurich
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- April 30, 2015
- Completion date
- September 30, 2018
- Enrollment
- 294 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.